Use of ketamine in treatment-resistant depression: an integrative review
DOI:
https://doi.org/10.33448/rsd-v11i16.37628Keywords:
Ketamine; Depressive disorder treatment-resistant; Therapy.Abstract
Depression is a disease that has appeared commonly and very frequently nowadays, however, it promotes disabling results in the minds of individuals in a global context. Given the above, the present study aims to analyze the effectiveness of the use of ketamine in patients with treatment-resistant depression. This is an integrative literature review, carried out in the SCIELO, LILACS, PubMed and CAPES Portal databases, during the period of September and October 2022, using the following descriptors “KETAMINE”, “TREATMENT-RESISTANT DEPRESSIVE DISORDER” and “THERAPEUTIC”, in addition, the descriptors were joined by the connectives “AND” and “OR”. Articles available in full, free of charge and published between 2015 and 2022 were used as inclusion criteria. As exclusion criteria, articles that do not address the issue of the use of ketamine in institutionalized treatment-resistant depression, duplicate studies and literature reviews . After collection through the established criteria, six articles were chosen, considering that they presented a random choice regarding the participants and the control group for the use of ketamine for the treatment of treatment-resistant depression. It is concluded that ketamine presented itself as a drug that presents a positive response for the treatment of treatment-resistant depression, in addition to presenting a rapid response and with few adverse effects. However, it is necessary to point out that although some tests had a small number of participants in their clinical trials, these trials described an inconsistent action of ketamine in relation to changes in the mood of the participants.
References
Alcantara, I. et. al. (2003). Avanços no diagnóstico do transtorno do humor bipolar. Revista de Psiquiatria, (15), 65.
Altinay, M., Karne, H. & Anand, A. (2019). Administration of Sub-anesthetic Dose of Ketamine and Electroconvulsive Treatment on Alternate Week Days in Patients with Treatment Resistant Depression: A Double-Blind Placebo Controlled Trial. Psychopharmacol Bull, 49 (1), 8-16.
Baptista, M. N. (2004). Suicídio e depressão: atualizações. Rio de Janeiro: Guanabara Koogan.
Bardin, L. (2016). Análise de conteúdo. Lisboa: Edições 70.
Brasil. (2018). Portaria n 1.876 de 14 de agosto de 2018. Diretrizes brasileiras para um plano nacional de prevenção do suicídio. Ministério da Saúde.
Braun, V. & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3 (2), 77-101.
Brunner & Suddarth (2005). Tratamento de enfermagem médico-cirúrgica. Rio de Janeiro: Smeltzer Bare.
Canale, A. & Furlan, M. M. D. P. (2006). Depressão. Arq Mudi., 10 (2), 23-31.
CAO, Z. et al. (2019). Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG. Ieee Transactions On Biomedical Engineering, 66 (6).
Cooper, M. D. et al. (2017) Strategies to mitigate dissociative and psychotomimetic effects of ketamine in the treatment of major depressive episodes: a narrative review. World J Biol. Psychiatry, 18 (6), 410-23.
Cordas, T. A. (2002). Do mau humor ao mal do humor: diagnóstico e tratamento. Porto Alegre: Artes Médicas.
Dalgalarrondo, P. (2015). Psicopatologia e semiologia dos transtornos mentais. 2. ed. Porto Alegre: Artmed S.A.
Filgueira, N. A., et al. (2007). Condutas em clínica médica. 4. ed. Rio de Janeiro: Medsi Guanabara Koogan.
Fontenelle, P. (2008). Suicídio: o futuro interrompido guia para sobreviventes. São Paulo: Geração Editorial.
Gabriel, P. (2007). Depressão: a tristeza que não encontra motivo na realidade. Ministério da Saúde.
Gil, A. C. (2010). Como elaborar projetos de pesquisa. 5. ed. São Paulo: Atlas.
Gil, A. C. (2019). Métodos e técnicas de pesquisa social. 7. ed. São Paulo: Atlas.
Han, Y., et al. (2016). Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies. Neuropsychiatr Dis Treat., 12, 2859-67.
Haq, A. U., et al. (2015). Response of depression to electroconvulsive therapy: a meta-analysis of clinical predictors. J Clin Psychiatry, 76 (10), 1374-1384.
Ionescu, D. F., et al. (2019). Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo-controlled trial. Journal of Affective Disorders, 15 (243), 516–524.
Johnston, K. M., et al. (2019). The burden of treatmentresistant depression: A systematic review of the economic and quality of life literature. J Affect Disord, 242, 195-210.
Kitchenham, B. A. (2007). Guidelines for performing Systematic Literature Reviews in Software Engineering. Durham: Universidade de Durham.
Lins, C. E., et al. (2006). Acompanhamento terapêutico: intervenção sobre a depressão e o suicídio. Psyche, 10 (18).
Louzã Neto. (2007). Psiquiatria básica. 2. ed. Porto Alegre: Artmed.
Mathew, S. J., et al. (2019). Electroconvulsive therapy (ECT) vs. Ketamine in patients with Treatment resistant Depression: The ELEKT-D study protoco. Contemporary Clinical Trials, 77, 19–26.
Mendes, K. D. S., Silveira, R. C. C. P. & Galvão, C. M. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto contexto - enferm., Florianópolis, 17 (4), 758-764.
Mohammed, A. & Mansour, I. A. (2020). Could ketamine be the answer to treating treatmentresistant major depressive disorder? Gen Psychiatr., 33 (5).
Naughton, M., et al. (2014). A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. J Affect Disord. 156, 24-35.
Oliveira, I. R. & Lima, P. A. P. (2003). Utilidades e limitações do uso de diretrizes no tratamento da depressão. Braz. J. Psychiatry, 25 (2).
Organização Mundial da Saúde. (2001). Banco de dados: Relatório sobre suicídio. Brasília: DF.
Paulo, M. S. L. L. (2005). Depressão e psicodiagnóstico interventivo: proposta de atendimento. São Paulo: Vetor.
Paganotto, A. (2007). Reflexões sobre Gestalt-terapia possibilidades e limites no tratamento da depressão do sujeito contemporâneo.
Phillips, J. L., et al. (2020). Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression. Neuropsychopharmacology, 45 (4), 606–612.
Singh, J. B., et al. (2016). A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression. Am J Psychiatry, 173 (8), 816-826.
Verwijk, E., et al. (2017). [Doctor, will I get my memory back? Electroconvulsive therapy and cognitive side-effects in daily practice]. Tijdschr. Psychiatr, 59 (10), 632-637.
Vieira, K. F. L. (2008). Representações sociais da depressão e do suicídio elaboradas por estudantes de psicologia. Universidade Federal da Paraíba.
William, A. K. (2009). Depressão. 2. ed. Rio de Janeiro: Guanabara Koogan.
Wolpert, L. (2003). Tristeza maligna: anatomia da depressão. São Paulo: Martins Fontes.
Zhong, X., et al. (2016). Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression. Journal of Affective Disorders, 201, 124–130.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Anderson Lima Mascarenhas; Marinalva Cerqueira Nascimento ; Marcos Paulo Santos Passos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
